Mutant of pyruvate carboxylase gene promoter and application of mutant in amino acid production

By designing and applying the promoter mutant of the pyruvate carboxylase gene with enhanced activity, the problem of insufficient expression intensity in the prior art was solved, significantly improving the production efficiency of amino acids, and achieving higher yield and conversion rates.

CN119061006APending Publication Date: 2024-12-03TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310638648.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-01
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

In the prior art, the expression intensity of the pyruvate carboxylase gene is insufficient, which limits the yield and conversion rate of amino acid-producing strains, and it is necessary to develop higher-active promoter elements to enhance gene expression.

Method used

Design and provide a mutant of the promoter of the pyruvate carboxylase gene with enhanced activity, which enhances its activity by introducing mutations at specific locations in the promoter nucleotide sequence and operably linking it to the target gene, Used to enhance the expression of genes related to amino acid synthesis.

Benefits of technology

It has achieved higher amino acid production efficiency, significantly improved the target product yield of the recombinant strain, and has high application value.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004260884910000051
    Figure BDA0004260884910000051
  • Figure BDA0004260884910000061
    Figure BDA0004260884910000061
  • Figure BDA0004260884910000071
    Figure BDA0004260884910000071
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and particularly relates to a mutant of a pyruvate carboxylase gene promoter and application of the mutant in amino acid production. The mutant is mutated from the 355th site to the 365th site of a promoter corresponding to a nucleotide sequence shown in SEQ ID NO.2, and has enhanced activity relative to a wild type promoter. The nucleic acid molecule with enhanced promoter activity provided by the invention shows higher promoter activity than a wild type, and can be used for expression of a target gene, especially expression of genes related to amino acid production, for example, the nucleic acid molecule is operably connected with a pyc gene, the expression intensity of pyruvate carboxylase can be enhanced, and the expression efficiency of pyruvate carboxylase is improved. Therefore, the amino acid production efficiency of the recombinant strain is improved, and the recombinant strain has high application value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biotechnology, and in particular relates to a mutant of a pyruvate carboxylase gene promoter and an application thereof in producing amino acids. Background Art

[0002] Amino acids are organic compounds containing alkaline amino groups and acidic carboxyl groups. They are the basic units of human and animal proteins, giving proteins specific molecular structures and biochemical activities. Common amino acids include 22 types such as glutamic acid, threonine, and lysine. They are widely used in industries such as medicine, health, food, animal feed, and cosmetics.

[0003] At present, amino acids are mainly produced by microbial fermentation, chemical synthesis, and protein hydrolysis and extraction, and microbial fermentation is the most important production method. The main production strains include Escherichia coli and Corynebacterium glutamicum. With the continuous development of biotechnology, there are more and more reports on metabolic engineering of production strains to increase their amino acid production, such as enhancing the expression of enzymes related to the amino acid synthesis pathway and reducing the expression of enzymes related to the competitive pathway.

[0004] Pyruvate carboxylase (encoded by pyc gene) is the rate-limiting enzyme of gluconeogenesis, which can catalyze pyruvate and carbon dioxide to generate oxaloacetate, thereby entering the tricarboxylic acid cycle. Prior art shows that strengthening the expression of pyruvate carboxylase can promote the production of target products with oxaloacetate as precursor, including aspartate family amino acids (lysine, threonine, isoleucine, methionine), glutamate family amino acids (glutamic acid, proline, hydroxyproline, arginine, glutamine), and 5-aminolevulinic acid and other amino acids with oxaloacetate as important metabolic precursors (such as CN110603321A, CN1275167A, CN103981203B, Peters-Wendisch PG, Schiel B, Wendisch VF, et al. Pyruvate carboxylase is a major bottleneck for glutamate and lysine production by Corynebacterium glutamicum. J Mol Microbiol Biotechnol, 2001, 3 (2): 295-300.) Therefore, researchers overexpressed pyc gene by increasing pyc gene copy number or replacing strong promoter, so as to increase the output of target product, such as CN113755492A, by mutating the core region of pyc gene promoter, obtained a series of pyc gene promoter mutants of different strengths, after applying these strong promoters to express pyc gene, increased the proline output of engineering strain. However, this area still needs to develop more highly active promoter elements, so as to further enhance the expression of genes such as pyc, thereby improving the output and conversion rate of bacterial strain target product. Summary of the invention

[0005] In view of the above-mentioned deficiencies and needs of the prior art, the present inventors have studied and searched for relevant promoters with enhanced activity and completed the present invention.

[0006] In a first aspect, the present invention provides a mutant of a pyruvate carboxylase gene promoter with improved promoter activity, wherein a mutation exists at positions 355 to 365 of the promoter corresponding to the nucleotide sequence shown in SEQ ID NO.2.

[0007] Further preferably, the nucleotide sequence of the mutant is shown in any one of SEQ ID NO: 3 to SEQ ID NO: 8.

[0008] The mutant of the pyruvate carboxylase gene promoter is a nucleotide molecule with promoter activity, and has enhanced activity relative to the wild-type promoter. The "promoter" refers to a nucleic acid molecule, which is usually located upstream of the target gene coding sequence, provides a recognition site for RNA polymerase, and is located upstream of the 5' direction of the mRNA transcription start site. It is a non-translated nucleic acid sequence, and RNA polymerase initiates the transcription of the target gene after binding to this nucleic acid sequence.

[0009] The gene encoding pyruvate carboxylase is the pyc gene, which is considered to be an enzyme that plays an important role in the anaplerotic pathway of Corynebacterium, and the enzyme can catalyze pyruvic acid and carbon dioxide to generate oxaloacetic acid, which is an important anaplerotic pathway of the tricarboxylic acid cycle. Existing a large amount of literature reports, over-expression of pyruvate carboxylase PYC can increase the amino acid (such as lysine, glutamic acid, threonine, etc.) output of bacterial strains.

[0010] The mutant of promoter of the present invention is the promoter of improved Corynebacterium glutamicum pyruvate carboxylase gene, and it has higher promoter activity than wild-type promoter.Promoter nucleic acid molecule of the present invention can use standard molecular biology techniques to separate or prepare.For example, can use suitable primer sequences to separate promoter nucleic acid molecule of the present invention through PCR.In addition, also can use automatic DNA synthesizer to prepare promoter nucleic acid molecule of the present invention through standard synthesis technique.

[0011] The nucleic acid molecule with promoter activity of the present invention can be used for the expression of other genes in Corynebacterium or Enterobacter, including but not limited to genes related to amino acid synthesis, such as aspartate kinase LysC, threonine operon ThrABC, aspartate semialdehyde dehydrogenase Asd, aspartate ammonia lyase AspB, homoserine dehydrogenase Hom, homoserine O-acetyltransferase MetX, dihydropicolinate synthetase DapA, dihydropicolinate reductase DapB, meso-diaminopimelate dehydrogenase Ddh, glutamate kinase ProB, glutamate-5-semialdehyde dehydrogenase ProA, pyrrole-5-carboxylate dehydrogenase ProC, proline dehydrogenase / pyrrole-5-carboxylate dehydrogenase PutA, 5-aminolevulinic acid synthetase HemA, etc.

[0012] The series of strong promoter elements of the present invention can be used to moderately regulate the expression of target genes and achieve efficient production of target products.

[0013] The term "Corynebacterium" as used in the present invention refers to a microorganism of the genus Corynebacterium, including but not limited to Corynebacterium glutamicum ATCC 13032, Corynebacterium glutamicum ATCC 13869, Corynebacterium glutamicum B253, Corynebacterium glutamicum ATCC 14067, and amino acid producing mutants or strains prepared from the above strains.

[0014] In a second aspect, the present invention provides an expression cassette and a recombinant vector comprising a mutant of the pyruvate carboxylase gene promoter.

[0015] The "expression cassette" has a meaning generally understood by those skilled in the art, ie, an element containing a promoter, a target gene and capable of expressing the target gene.

[0016] The term "vector" refers to a DNA construct containing a DNA sequence operably linked to an appropriate control sequence, so as to express a target gene in a suitable host. The vector used in the present invention is not particularly limited and can be any vector known in the art, as long as it can be replicated in the host. That is, the vector includes but is not limited to plasmids, phages, such as the pEC-XK99E plasmid used in the specific embodiment of the present invention. Once transformed into a suitable host, the vector can replicate and function independently of the host genome, or in some cases integrate into the genome itself.

[0017] In a third aspect, the present invention provides a recombinant host cell containing the mutant of the pyruvate carboxylase gene promoter.

[0018] Recombination of host cells is achieved, for example, by transformation. Here, "transformation" has the meaning generally understood by those skilled in the art, that is, the process of introducing exogenous DNA into a host. The transformation method includes any method for introducing nucleic acid into cells, including but not limited to electroporation, calcium phosphate (CaPO), 4 ) precipitation method, calcium chloride (CaCl 2 ) precipitation method, microinjection method, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method and lithium acetate-DMSO method.

[0019] "Host cell" of the present invention has the meaning that those of ordinary skill in the art usually understand, that is, can import the cell of the nucleic acid with promoter activity of the present invention, is called recombinant host cell after importing. In other words, the present invention can utilize any host cell, as long as its cell contains the nucleic acid with promoter activity of the present invention, and is operably connected with a certain gene to mediate the transcription of this gene.Host cell of the present invention can be a prokaryotic cell or a eukaryotic cell, preferably enterobacterium or corynebacterium, more preferably Corynebacterium glutamicum, including but not limited to Corynebacterium glutamicum ATCC 13032, Corynebacterium glutamicum ATCC 13869, Corynebacterium glutamicum B253, Corynebacterium glutamicum ATCC 14067, and the mutant or the bacterial strain of the L-amino acid produced by the above-mentioned bacterial strain preparation.

[0020] In some embodiments, the glutamate producing strain may be a strain obtained by transformation based on Corynebacterium glutamicum ATCC 13032 or Corynebacterium glutamicum ATCC13869, wherein the transformation includes but is not limited to one or more genes selected from the following being enhanced or overexpressed:

[0021] a. yggB gene encoding mechanosensitive channel protein (CN108250278A);

[0022] b. fxpk gene encoding phosphoketolase (WO2006016705A1);

[0023] c. pyc gene encoding pyruvate carboxylase (WO2004069996A2);

[0024] d. gdh gene encoding glutamate dehydrogenase (CN103205390A);

[0025] e. Gene encoding carbonic anhydrase (WO2011024583A1).

[0026] In some embodiments, the glutamate producing strain may also have one or more genes selected from the group consisting of, but not limited to, the following attenuated or reduced in expression:

[0027] a. odhA gene encoding α-ketoglutarate dehydrogenase (WO2006028298A2);

[0028] b. amtR gene encoding a transcriptional regulatory gene (EP2276845A1);

[0029] c. acnR gene encoding a transcription repressor (CN111334535A).

[0030] In a specific embodiment of the present invention, the host cell is Corynebacterium glutamicum, which is further improved by introducing A111V mutation into the NCgl1221 homologous gene (BBD29_06760 or yggB) in the bacterium, C361Y mutation into the gltA gene, and P gltA-Ts24 The glutamate-producing strain SCgGC9 was obtained by introducing P gdh-RBS19 Promoter mutants were used to obtain the glutamate-producing strain SCgGC16.

[0031] In the present invention, the host cells can be cultured according to conventional methods in the art, including but not limited to well plate culture, shake flask culture, batch culture, continuous culture and fed-batch culture, etc., and various culture conditions such as temperature, time and pH value of the culture medium can be appropriately adjusted according to actual conditions.

[0032] In a fourth aspect, the present invention provides a method for enhancing the expression of a target gene, the method comprising operably linking a mutant of the pyruvate carboxylase gene promoter to the target gene, preferably enhancing the expression of genes related to the synthesis of the target product with oxaloacetate as a precursor.

[0033] The term "operably connected" in the present invention refers to that the mutant of the pyruvate carboxylase gene promoter of the present invention is functionally connected to the coding gene to start and mediate the transcription of the gene, indicating that the mutant of the pyruvate carboxylase gene promoter of the present invention is operably connected to the coding gene to control the transcription activity of the operon gene. The operably connected mode can adopt any mode described by those skilled in the art. In the method for enhancing the expression of the target gene of the present invention, based on the mutant of the pyruvate carboxylase gene promoter of the present invention, the method commonly used by those skilled in the art is adopted to achieve.

[0034] In a fifth aspect, the present invention provides a production method of a target product with oxaloacetate as a precursor, the method comprising cultivating a host cell in which a mutant containing the pyruvate carboxylase gene promoter is operably connected to a gene related to the synthesis of the target product with oxaloacetate as a precursor, and collecting the target product produced. Wherein, the target product with oxaloacetate as a precursor includes but is not limited to amino acids and derivatives thereof, the amino acids include aspartate family amino acids (lysine, threonine, isoleucine, methionine), glutamate family amino acids (glutamic acid, proline, hydroxyproline, arginine, glutamic acid amide), and 5-aminolevulinic acid, etc., and the derivatives include but are not limited to pentamethylenediamine, glutaric acid, etc. By the method of the present invention, the yield of the target product with oxaloacetate as a precursor of the strain can be increased. More specifically, the gene related to the synthesis of the target product with oxaloacetate as a precursor is selected from pyc gene, lysC gene, thrABC gene, asd gene, aspB gene, hom gene, metX gene, dapA gene, dapB gene, ddh gene, proB gene, proA gene, proC gene, putA gene, hemA gene, etc.

[0035] In the method for producing the target product with oxaloacetate as a precursor of the present invention, based on the mutant of the pyruvate carboxylase gene promoter of the present invention, a method commonly used by those skilled in the art is adopted, and the step of recovering the target product from cells or culture medium is also included. The method of recovering the target product from cells or culture medium is well known in the art, including but not limited to: filtration, anion exchange chromatography, crystallization and HPLC.

[0036] Beneficial effects of the present invention: The nucleic acid molecule with enhanced promoter activity provided by the present invention exhibits higher promoter activity than the wild type, and can be used for the expression of target genes, especially the expression of genes related to amino acid production. For example, it can be operably linked to the pyc gene to enhance the expression intensity of pyruvate carboxylase, thereby improving the amino acid production efficiency of the recombinant strain, and has a high application value. DETAILED DESCRIPTION

[0037] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. Although any methods and materials similar or equivalent to those described herein can be used to implement or test the present invention, the methods and materials described herein are preferred.

[0038] The present invention will be further described below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not intended to limit the scope of the present invention. The experimental techniques and experimental methods used in the present embodiment are all conventional technical methods unless otherwise specified. For example, the experimental methods in the following examples that do not specify specific conditions are usually carried out according to conventional conditions such as Sambrook et al., Molecular Cloning: Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the conditions recommended by the manufacturer. The materials, reagents, etc. used in the embodiments, unless otherwise specified, can all be obtained through regular commercial channels.

[0039] The culture medium used in the examples is as follows:

[0040] The composition of TSB plate medium is (g / L): glucose, 5g / L; yeast powder, 5g / L; soy peptone, 9g / L; urea, 3g / L; succinic acid, 0.5g / L; K 2 HPO 4 ·3H 2 O, 1 g / L; MgSO 4 7H 2 O, 0.1g / L; biotin, 0.01mg / L; vitamin B1, 0.1mg / L; MOPS, 20g / L; agar powder, 15g / L.

[0041] The components of TSB liquid medium are (g / L): glucose, 5g / L; yeast powder, 5g / L; soy peptone, 9g / L; urea, 3g / L; succinic acid, 0.5g / L; K 2 HPO 4 ·3H 2 O, 1 g / L; MgSO 4 7H 2O, 0.1g / L; biotin, 0.01mg / L; vitamin B1, 0.1mg / L; MOPS, 20g / L.

[0042] The seed culture medium used in the glutamate fermentation experiment was composed of glucose, 25 g / L; KH 2 PO 4 ·3H 2 O, 2.2 g / L; urea, 3 g / L; corn steep liquor, 33 mL; MgSO 4 7H 2 O, 0.9 g / L; soybean cake hydrolyzate, 22 mL; MOPS, 20 g / L; initial pH 7.2.

[0043] The fermentation medium used in the glutamate fermentation experiment was composed of glucose, 80 g / L; KH 2 PO 4 , 1g / L; urea, 10g / L; corn steep liquor powder, 5g / L; MgSO 4 7H 2 O, 0.4 g / L; FeSO 4 7H 2 O, 10 mg / L; MnSO 4 ·4H 2 O, 10mg / L; VB 1 , 200μg / L; MOPS, 40g / L; initial pH 7.5.

[0044] Example 1 Characterization of the Corynebacterium glutamicum pyc promoter

[0045] (1) Construction of wild-type pyc promoter characterization vector

[0046] According to the published genome sequence of Corynebacterium glutamicum ATCC 13869 (GenBank: CP016335.1), primers pyc-1 / 2 were designed and amplified using the ATCC 13869 genome as a template to amplify the wild-type promoter P of the pyc gene. pyc-WT(The sequence is shown in SEQ ID NO: 1) and a fragment of the N-terminal 180bp sequence. Using the pEC-XK99E-rfp plasmid reported in the literature (Wang Yingchun et al. Screening of endogenous efficient constitutive promoters of Corynebacterium glutamicum based on time series transcriptome [J]. Journal of Biotechnology, 2018, 34(11): 1760-1771) as a template, PEC-1 / 2 was used as a primer to amplify the pEC-XK99E plasmid backbone, and RFP-1 / 2 was used as a primer to amplify the red fluorescent protein gene DNA fragment containing the connecting peptide (DNA sequence: GGCGGTGGC TCTGGAGGTGGTGGGTCCGGCGGTGGCTCT). The primers used in this example are shown in Table 1. After the above fragments were recovered and purified, they were cloned and connected using the one-step recombination kit of Novozymes to obtain pEC-XK99E-P pyc-WT -RFP characterizes the vector.

[0047] Table 1. Primers for constructing characterization vectors

[0048]

[0049] (2) Characterization of different pyc promoter strengths

[0050] The inventor's team previously constructed and obtained a series of strong promoter elements based on the pyc promoter of Corynebacterium glutamicum ATCC13032 (reference CN113755492A). In order to test the activity of different promoters in Corynebacterium glutamicum ATCC13869, the inventors isolated the wild-type pyc promoter P from the ATCC13869 source. pyc-WT As well as the different strength promoters P obtained in the early screening pyc-3 , P pyc-9 , P pyc-13 and P pyc-20 (Plasmid information and construction process refer to CN113755492A) intensity characterization was carried out. The above-mentioned characterization vectors were transformed into Corynebacterium glutamicum ATCC 13869, and were respectively coated on TSB solid plates containing 25μg / mL kanamycin. The transformants were inoculated with a pipette tip into a 24-well plate containing 800μLTSB liquid culture medium in each well. Each strain was replicated 3 times. The plate shaker speed was 800rpm. After culturing at 30°C for 16h, the fluorescence intensity of the strain was detected using an enzyme reader. The excitation wavelength of the fluorescence measurement was 560nm and the emission wavelength was 607nm; at the same time, the OD of the bacterial solution was measured. 600 , calculated the fluorescence intensity of the strains, and the results are shown in Table 2. It can be seen that the activities of all mutant promoters are higher than that of the wild-type pyc promoter in ATCC13869, but the overall trend is different from that in ATCC13032, indicating that the activities of the same promoter in different host strains may vary, among which P pyc-13The promoter activity was the highest, 3.95 times that of the wild-type promoter.

[0051] Table 2. Fluorescence characterization of pyc promoter mutants

[0052] Promoter number <![CDATA[Fluorescence intensity (RFU / OD 600 )]]> Multiples of wild type The sequence number of the complete promoter sequence <![CDATA[P pyc-WT ]]> 227.12 —— SEQ ID NO: 1 <![CDATA[P pyc-13 ]]> 897.09 3.95 SEQ ID NO: 2 <![CDATA[P pyc-3 ]]> 635.09 2.80 SEQ ID NO: 9 <![CDATA[P pyc-9 ]]> 851.22 3.75 SEQ ID NO: 10 <![CDATA[P pyc-20 ]]> 602.33 2.65 SEQ ID NO: 11

[0053] Example 2 Screening and Strength Characterization of RBS Region Mutation of Pyc Gene Promoter of Corynebacterium glutamicum

[0054] (1) Construction and preliminary screening of promoter mutant library

[0055] In order to further improve the strength of the pyc promoter in ATCC13869, this embodiment selects the P with the highest strength in ATCC13869. p yc-13 The promoter was subjected to RBS region mutation library construction, and the "NNNRRRRRNNN" mutation was introduced in the RBS region (position 355 to 365).

[0056] pEC-XK99E-P pyc-13 -rfp characterization vector was used as a template, and primers RBS-pyc-F and RBS-pyc-R were used to amplify the fragment containing the RBS region mutation. After terminal phosphorylation treatment by T4 PNK, the fragment was ligated with T4 ligase. All clones obtained after transformation were collected and plasmids were extracted to obtain P pyc-13 Plasmid library of mutants of the RBS region of the promoter.

[0057] The above plasmid library was transformed into Corynebacterium glutamicum ATCC13869, and coated on a TSB solid plate containing 25 μg / mL kanamycin. The plate with hundreds of clones was photographed by a fluorescent imaging system, and mutants with improved expression intensity were preliminarily screened based on the fluorescence brightness of the clones. pyc-WT -rfp and pEC-XK99E-P pyc-13 -rfp characterization plasmids were transformed into Corynebacterium glutamicum ATCC13869 to obtain control strains. The primer sequences used above are as follows: RBS-pyc-F: ACCCTTGGCGGTCTCTTGTTNNNRRRRRNNNTTACTCTAGTGTCGACTCAC; RBS-pyc-R: GATAGCAGTCACTGCGTAAA.

[0058] (2) Characterization and sequence analysis of promoter mutant library

[0059] The mutants with enhanced fluorescence brightness shown by fluorescence imaging in the above plates were cultured in 96-well plates to characterize the strength of the promoter. pyc-WT and P pyc-13 The control strains were inoculated into 96-well plates containing 200 μL TSB liquid medium in each well with a pipette tip. 25 μg / mL kanamycin was added to the medium. Each strain was cultured in parallel for 3 times. The plate shaker speed was 800 rpm. After culturing at 30°C for 16 hours, the fluorescence intensity of the strain was detected by an ELISA reader. The excitation wavelength of the fluorescence determination was 560 nm and the emission wavelength was 607 nm. At the same time, the OD value of the bacterial solution was determined. 600 Calculate the fluorescence intensity of the strain. pyc-13 The pEC-F (TACGGTTCCTGGCCTTTTGC) and RFP-CX (CGGGTGTTTAACGTAAGCTTTG) primers were used to amplify the fragment containing the mutation region and sequence analysis. The results are shown in Table 3. Finally, 6 expression intensities of P pyc-WT The promoter mutants with improved promoters (nucleotide sequences shown in SEQ ID NO: 3 to SEQ ID NO: 5, respectively) had expression intensities 6.77-10.83 times that of the wild type. pyc-13 The promoter activity of the promoter mutants was also improved to varying degrees.

[0060] Table 3. Fluorescence characterization of pyc promoter RBS mutants

[0061]

[0062]

[0063] Example 3 Application of Corynebacterium glutamicum pyc gene promoter mutant in L-glutamic acid production

[0064] (1) Construction of L-glutamic acid high-yielding strain

[0065] In order to verify the effect of pyc gene promoter mutants on glutamate synthesis, we modified a strain with glutamate synthesis ability, SCgGC9 (for strain information and construction process, refer to CN115927325A).

[0066] Primers were designed based on the published sequence of the Corynebacterium glutamicum ATCC 13869 genome (GenBank: CP016335.1). Pgdh-UH-F / R and Pgdh-DH-F / R were used as primers, and the ATCC 13869 genome was used as a template to amplify the upstream and downstream homology arm fragments; RBS19-F / R was used as primers, and the plasmid carrying the SEQ ID NO: 5 sequence in patent CN115948396A was used as a template to amplify the P gdh-RBS19 The mutant fragments were obtained by designing primers pK-F / R based on the sequence information of plasmid pK18mobsacB, and using plasmid pK18mobsacB as a template, a linearized vector fragment was obtained by reverse PCR amplification. The above four fragments were recovered and recombined to obtain a fragment with P gdh-RBS19 The editing plasmid pK18-P of the mutant gdh-RBS19 The L-glutamic acid production strain SCgGC9 competent cells were prepared by the method reported in the literature (Biotechnology Letters, 2015, 37: 2445-52.), and 1 μg of pK18-P was electroporated into the prepared SCgGC9 competent cells. gdh-RBS19 Plasmid, add 1mL of TSB medium preheated at 46℃, incubate at 46℃ for 6min, incubate at 30℃ for 3h, apply TSB solid medium containing 25μg / mL kanamycin, and culture at 30℃ for 1 day to obtain the first recombinant transformant. The correct transformant was transferred to TSB medium containing 5g / L glucose for overnight culture, and then transferred to TSB medium containing 100g / L sucrose. After culturing at 30℃ for 4h, it was applied to TSB medium supplemented with 100g / L sucrose for screening, and strain SCgGC16, namely SCgGC9-P gdh-RBS19 The mutant strain has higher glutamate production than SCgGC9.

[0067] (2) Construction of pyc promoter mutant strain

[0068] Ppyc-UH-F / R and Ppyc-DH-F / R were used as primers, and ATCC 13869 genome was used as template to amplify the gene containing P pyc-RBS20 The upstream and downstream fragments of the mutant. Using pK-F / R as primers and plasmid pK18mobsacB as template, a linearized vector fragment was obtained by reverse PCR amplification. The above three fragments were recovered and recombined to obtain a fragment with P pyc-RBS20 The editing plasmid pK18-P of the mutant pyc-RBS20The L-glutamic acid production strain SCgGC16 competent cells were prepared by the method reported in the literature (Biotechnology Letters, 2015, 37: 2445-52.), and 1 μg of pK18-P was electroporated into the prepared SCgGC16 competent cells. pyc-RBS20 Plasmid, add 1mL of TSB medium preheated at 46℃, incubate at 46℃ for 6min, incubate at 30℃ for 3h, apply TSB solid medium containing 25μg / mL kanamycin, and culture at 30℃ for 1 day to obtain the first recombinant transformant. The correct transformant was transferred to TSB medium containing 5g / L glucose for overnight culture, and then transferred to TSB medium containing 100g / L sucrose. After culturing at 30℃ for 4h, it was applied to TSB medium supplemented with 100g / L sucrose for screening, and strain SCgGC18, namely SCgGC16-P, was obtained. pyc-RBS20 Mutant bacteria. The primers used in this example are shown in Table 4.

[0069] Table 4. Primers used in this example

[0070]

[0071]

[0072] (3) Effect of mutant pyc promoter on L-glutamate synthesis

[0073] In order to verify the effect of the pyc promoter mutant on L-glutamate production, fermentation tests were performed on the SCgGC16 and SCgGC18 strains constructed above, and ATCC 13869 was used as a control strain.

[0074] First, the strain was inoculated into seed culture medium and cultured for 8 h. The culture was inoculated as seeds into 24-well plates containing 800 μL of fermentation medium per well. The initial OD 600 The control was about 0.5, the speed of the orifice shaker was 800 rpm, 3 parallels were made for each strain, the culture was carried out at 30°C, the pH value was measured at 23h and 2g / L urea was added, the fermentation was ended at 25h, the L-glutamic acid production and glucose consumption were detected, and the sugar-acid conversion rate from glucose to L-glutamic acid was calculated. The results are shown in Table 5.

[0075] Table 5. L-Glutamic Acid Production

[0076] strain <![CDATA[OD 600 ]]> L-Glutamic acid (g / L) Sugar-acid conversion rate (g / g, %) ATCC 13869 11.70±0.07 0.20±0.00 0.27±0.00 SCgGC16 11.54±0.08 9.53±0.42 14.49±0.61 SCgGC18 9.04±0.48 11.60±0.00 20.79±0.32

[0077] From the table, we can see that P pyc-RBS20 The L-glutamic acid yield and sugar-acid conversion rate can be significantly improved. It can be seen that the pyc promoter mutant obtained by the present invention has a good application prospect in the production of L-glutamic acid and its derivatives.

Claims

1. A mutant of a pyruvate carboxylase gene promoter with improved promoter activity, wherein a mutation exists at positions 355 to 365 of the promoter corresponding to the nucleotide sequence shown in SEQ ID NO.2, and the promoter has enhanced activity relative to the wild-type promoter; Preferably, the nucleotide sequence of the mutant is shown in any one of SEQ ID NO: 3 to SEQ ID NO:

8.

2. An expression cassette or a recombinant vector comprising the mutant of the pyruvate carboxylase gene promoter as claimed in claim 1.

3. A recombinant host cell containing the mutant of the pyruvate carboxylase gene promoter as claimed in claim 1, or an expression cassette thereof.

4. The host cell according to claim 3, characterized in that The host cell is a prokaryotic cell or a eukaryotic cell, preferably an Enterobacterium or a Corynebacterium, more preferably Corynebacterium glutamicum.

5. The host cell according to claim 4, characterized in that The host cell is Corynebacterium glutamicum ATCC13032, Corynebacterium glutamicum ATCC 13869, Corynebacterium glutamicum B253, Corynebacterium glutamicum ATCC 14067, and a mutant or strain producing L-amino acid prepared from the above strains.

6. The recombinant host cell according to claim 5, characterized in that The host cell is a strain obtained by transformation based on Corynebacterium glutamicum ATCC 13032 and Corynebacterium glutamicum ATCC13869, wherein the transformation includes but is not limited to one or more genes selected from the following being enhanced or overexpressed: a. Encoding mechanosensitive channel proteins ygB Gene; b. Encoding phosphoketolase fxpk Gene; c. Encoding pyruvate carboxylase pyc Gene; d. Encoding glutamate dehydrogenase gd Gene; e. Gene encoding carbonic anhydrase.

7. The recombinant host cell according to claim 6, characterized in that The glutamate producing strain may also include, but is not limited to, one or more genes selected from the following being weakened or having reduced expression: a. Encoding α-ketoglutarate dehydrogenase odhA Gene; b. Encoding transcriptional regulatory genes ikB Gene; c. Encoding transcriptional repressors acn Gene.

8. The recombinant host cell according to claim 7, characterized in that The Corynebacterium glutamicum is further improved, wherein NCgl1221 Introducing A111V mutation into homologous gene, C361Y mutation into GltA encoding gene, or gltA Gene promoter introduction gltA-Ts24 Mutation, or introduction of P gdh-RBS19 Glutamate-producing strains obtained by using promoter mutants.

9. A method for enhancing the expression of a target gene, the method comprising operably linking the mutant of the pyruvate carboxylase gene promoter as claimed in claim 1 to the target gene, preferably enhancing the expression of genes related to the synthesis of the target product with oxaloacetate as a precursor.

10. A method for producing a target product using oxaloacetate as a precursor, the method comprising culturing a host cell containing a mutant of the pyruvate carboxylase gene promoter as claimed in claim 1 and a gene related to the synthesis of the target product using oxaloacetate as a precursor operably linked, and collecting the produced target product; in, The target product with oxaloacetate as a precursor includes, but is not limited to, amino acids and their derivatives, wherein the amino acids include aspartic acid family amino acids (e.g., lysine, threonine, isoleucine, methionine), glutamic acid family amino acids (glutamic acid, proline, hydroxyproline, arginine, glutamic acid amide), or 5-aminolevulinic acid, wherein the derivatives include, but are not limited to, pentamethylenediamine, glutaric acid, etc.; More specifically, genes related to the synthesis of target products using oxaloacetate as a precursor are selected from pyc Gene, lysC Gene, thrABC Gene, asd Gene, aspB Gene, hom Gene, metX Gene, dapA Gene, dapB Gene, dhdh Gene, proB Gene, proA Gene, proC Gene, putA Gene, hemA Genes, etc.